Continuous Glucose Monitoring MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy Product TypeBy Sensor Wear DurationBy Sensing TechnologyBy ApplicationBy Age GroupBy Connectivity and IntegrationBy End UserBy Distribution ChannelBy Reimbursement Status
Full title & scope — all 10 axes with their segments
Continuous Glucose Monitoring Market Size, Share & Industry Analysis, By Component (Sensors, Transmitters, Receivers and Readers, Software and Data Platforms, Insertion and Accessories), By Product Type (Real-Time CGM, Intermittently Scanned CGM, Professional CGM, Over-the-Counter CGM), By Sensor Wear Duration (Up to 7 Days, 8 to 10 Days, 11 to 15 Days, Beyond 15 Days), By Sensing Technology (Minimally Invasive Enzymatic Electrochemical, Implantable Fluorescence-Based, Non-Invasive, Microneedle-Based), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes and Metabolic Health, Hospital Glycemic Management), By Age Group (Pediatric, Adult, Geriatric), By Connectivity and Integration (Standalone CGM, Integrated with Insulin Pumps, Integrated with Smart Pens, Open-Source and Third-Party Integrated), By End User (Home Care Settings, Hospitals, Clinics and Endocrinology Centers, Ambulatory Surgical and Long-Term Care Facilities, Research and Clinical Trial Organizations), By Distribution Channel (Retail Pharmacies, Online Pharmacies and E-Commerce, Direct-to-Consumer / Manufacturer Direct, Durable Medical Equipment Suppliers, Hospital Pharmacies), By Reimbursement Status (Public Insurance Reimbursed, Private Insurance Reimbursed, Out-of-Pocket), and Regional Forecast, 2026-2034
Last Updated: Nov 6, 2026Format: PDFReport ID: CDI-248862
TOC
Full table of contents for the published report, chapter by chapter.
Full chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
1.1Strategic Imperatives
1.2Definition
1.3Continuous Glucose Monitoring Comparison By Segments
Chapter 2.Premium Insights
2.1Top 3 Trends to Watch
2.2Top 3 Strategies Followed by Major Players
2.3Top 3 Predictions by Contrive Datum Insights
2.4Top Investment Pockets
2.4.1Market Attractiveness Analysis, By Component
2.4.2Market Attractiveness Analysis, By Product Type
2.4.3Market Attractiveness Analysis, By Sensor Wear Duration
2.4.4Market Attractiveness Analysis, By Sensing Technology
2.4.5Market Attractiveness Analysis, By Application
2.4.6Market Attractiveness Analysis, By Age Group
2.4.7Market Attractiveness Analysis, By Connectivity and Integration
2.4.8Market Attractiveness Analysis, By End User
2.4.9Market Attractiveness Analysis, By Distribution Channel
2.4.10Market Attractiveness Analysis, By Reimbursement Status
2.5Key Market Participants — Intensity Mapping
2.6Insights From Primary Respondents
Chapter 3.Market Definition
Chapter 4.Research Methodology
4.1Research Approach
4.1.1Research Programs / Design
4.1.2Market Size Estimation
4.2Data Sources
4.2.1Secondary Sources
4.2.1.1Preliminary Data Mining
4.2.2Primary Sources
4.2.2.1Statistical Model
4.2.2.2Data Triangulation
4.2.2.3Research Objective
4.3Flow Of Methodology
4.4Top-Down / Bottom-Up Approach
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
6.1Market Focus & Value Proposition
6.1.1Target Customers, Priority Markets, and Core Value Proposition
6.1.2Product Differentiation and Positioning Logic
6.2Commercial Model & Pricing Strategy
6.2.1Pricing Approach and Value Capture
6.2.2Contracting, Bundling, and Monetization Framework
6.3Channels, Sales & Partnerships
6.3.1Direct and Indirect Channel Strategy
6.3.2Sales Execution Model and Strategic Partnerships
6.4Marketing, Launch & Execution Roadmap
6.4.1Marketing and Demand Generation Approach
6.4.2Launch Sequencing and Rollout Plan
6.5Operational Readiness & Governance KPIs
6.5.1Supply Chain and Operational Preparedness
6.5.2Regulatory Considerations, Risks, and Performance Tracking
Chapter 7.Market Trends, Strategy & Dynamics
7.1Trends Overview
7.2Strategic Overview
7.3Market Drivers
7.4Market Restraints
7.5Market Opportunities
7.6Market Challenges
7.7Impact Analysis of Market Dynamics
Chapter 8.Porter's Five Forces
8.1Bargaining Power of Suppliers
8.2Bargaining Power of Buyers
8.3Threat of New Entrants
8.4Threat of Substitutes
8.5Competitive Rivalry
Chapter 9.PESTEL Analysis
9.1Political
9.2Economic
9.3Social
9.4Technological
9.5Environmental
9.6Legal
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
12.1Macro-Economic Factors Overview
12.2Forecast Factors — Relevance and Impact
Chapter 13.Market Cost Analysis
13.1Key Raw Materials Analysis
13.1.1Key Raw Materials
13.1.2Price Trend of Key Raw Materials
13.1.3Key Suppliers of Raw Materials
13.1.4Market Concentration Rate of Raw Materials
13.1.5Raw Materials
13.1.6Labor Cost
Chapter 14.Market Supply-Side Analysis
14.1Raw Materials
14.2Price Trends
14.3Industry Chain
14.4Raw Materials Sourcing
14.5Raw Materials Sources of Major Manufacturers
14.6Downstream Buyers
Chapter 15.Global Continuous Glucose Monitoring Market Size & Projections, 2020–2034, Revenue (USD Billion)
15.1Global Continuous Glucose Monitoring Market Size — Total
15.2Market Size, by Segment (By Component, By Product Type, By Sensor Wear Duration, By Sensing Technology, By Application, By Age Group, By Connectivity and Integration, By End User, By Distribution Channel, By Reimbursement Status)
Chapter 16.Global Continuous Glucose Monitoring Market Overview, By Component, 2020–2034, Revenue (USD Billion)
16.1Introduction
16.2Global Continuous Glucose Monitoring Market Size, By Component, 2020–2034, Revenue (USD Billion)
16.3Global Continuous Glucose Monitoring Market Share, By Component (%)
16.3.1Sensors
16.3.1.1Market Size, By Sensors, 2020–2034, Revenue (USD Billion)
16.3.1.2Sensors Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
16.3.1.3Sensors Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
16.3.1.4Sensors Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
16.3.1.5Sensors Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
16.3.1.6Sensors Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
16.3.1.7Sensors Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
16.3.1.8Sensors Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
16.3.1.9Sensors Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
16.3.1.10Sensors Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
16.3.2Transmitters
16.3.3Receivers and Readers
16.3.4Software and Data Platforms
16.3.5Insertion and Accessories
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 16.3.1 (Sensors).
Chapter 17.Global Continuous Glucose Monitoring Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
17.1Introduction
17.2Global Continuous Glucose Monitoring Market Size, By Product Type, 2020–2034, Revenue (USD Billion)
17.3Global Continuous Glucose Monitoring Market Share, By Product Type (%)
17.3.1Real-Time CGM (rtCGM)
17.3.1.1Market Size, By Real-Time CGM (rtCGM), 2020–2034, Revenue (USD Billion)
17.3.1.2Real-Time CGM (rtCGM) Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
17.3.1.3Real-Time CGM (rtCGM) Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
17.3.1.4Real-Time CGM (rtCGM) Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
17.3.1.5Real-Time CGM (rtCGM) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
17.3.1.6Real-Time CGM (rtCGM) Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
17.3.1.7Real-Time CGM (rtCGM) Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
17.3.1.8Real-Time CGM (rtCGM) Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
17.3.1.9Real-Time CGM (rtCGM) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
17.3.1.10Real-Time CGM (rtCGM) Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
17.3.2Intermittently Scanned CGM (isCGM / Flash)
17.3.3Professional CGM
17.3.4Over-the-Counter CGM
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 17.3.1 (Real-Time CGM (rtCGM)).
Chapter 18.Global Continuous Glucose Monitoring Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
18.1Introduction
18.2Global Continuous Glucose Monitoring Market Size, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
18.3Global Continuous Glucose Monitoring Market Share, By Sensor Wear Duration (%)
18.3.1Up to 7 Days
18.3.1.1Market Size, By Up to 7 Days, 2020–2034, Revenue (USD Billion)
18.3.1.2Up to 7 Days Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
18.3.1.3Up to 7 Days Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
18.3.1.4Up to 7 Days Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
18.3.1.5Up to 7 Days Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
18.3.1.6Up to 7 Days Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
18.3.1.7Up to 7 Days Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
18.3.1.8Up to 7 Days Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
18.3.1.9Up to 7 Days Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
18.3.1.10Up to 7 Days Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
18.3.28 to 10 Days
18.3.311 to 15 Days
18.3.4Beyond 15 Days
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 18.3.1 (Up to 7 Days).
Chapter 19.Global Continuous Glucose Monitoring Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
19.1Introduction
19.2Global Continuous Glucose Monitoring Market Size, By Sensing Technology, 2020–2034, Revenue (USD Billion)
19.3Global Continuous Glucose Monitoring Market Share, By Sensing Technology (%)
19.3.1Minimally Invasive Enzymatic Electrochemical
19.3.1.1Market Size, By Minimally Invasive Enzymatic Electrochemical, 2020–2034, Revenue (USD Billion)
19.3.1.2Minimally Invasive Enzymatic Electrochemical Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
19.3.1.3Minimally Invasive Enzymatic Electrochemical Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
19.3.1.4Minimally Invasive Enzymatic Electrochemical Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
19.3.1.5Minimally Invasive Enzymatic Electrochemical Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
19.3.1.6Minimally Invasive Enzymatic Electrochemical Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
19.3.1.7Minimally Invasive Enzymatic Electrochemical Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
19.3.1.8Minimally Invasive Enzymatic Electrochemical Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
19.3.1.9Minimally Invasive Enzymatic Electrochemical Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
19.3.1.10Minimally Invasive Enzymatic Electrochemical Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
19.3.2Implantable Fluorescence-Based
19.3.3Non-Invasive
19.3.4Microneedle-Based
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 19.3.1 (Minimally Invasive Enzymatic Electrochemical).
Chapter 20.Global Continuous Glucose Monitoring Market Overview, By Application, 2020–2034, Revenue (USD Billion)
20.1Introduction
20.2Global Continuous Glucose Monitoring Market Size, By Application, 2020–2034, Revenue (USD Billion)
20.3Global Continuous Glucose Monitoring Market Share, By Application (%)
20.3.1Type 1 Diabetes
20.3.1.1Market Size, By Type 1 Diabetes, 2020–2034, Revenue (USD Billion)
20.3.1.2Type 1 Diabetes Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
20.3.1.3Type 1 Diabetes Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
20.3.1.4Type 1 Diabetes Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
20.3.1.5Type 1 Diabetes Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
20.3.1.6Type 1 Diabetes Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
20.3.1.7Type 1 Diabetes Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
20.3.1.8Type 1 Diabetes Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
20.3.1.9Type 1 Diabetes Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
20.3.1.10Type 1 Diabetes Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
20.3.2Type 2 Diabetes
20.3.3Gestational Diabetes
20.3.4Prediabetes and Metabolic Health
20.3.5Hospital Glycemic Management
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 20.3.1 (Type 1 Diabetes).
Chapter 21.Global Continuous Glucose Monitoring Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
21.1Introduction
21.2Global Continuous Glucose Monitoring Market Size, By Age Group, 2020–2034, Revenue (USD Billion)
21.3Global Continuous Glucose Monitoring Market Share, By Age Group (%)
21.3.1Pediatric (0 to 17 Years)
21.3.1.1Market Size, By Pediatric (0 to 17 Years), 2020–2034, Revenue (USD Billion)
21.3.1.2Pediatric (0 to 17 Years) Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
21.3.1.3Pediatric (0 to 17 Years) Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
21.3.1.4Pediatric (0 to 17 Years) Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
21.3.1.5Pediatric (0 to 17 Years) Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
21.3.1.6Pediatric (0 to 17 Years) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
21.3.1.7Pediatric (0 to 17 Years) Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
21.3.1.8Pediatric (0 to 17 Years) Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
21.3.1.9Pediatric (0 to 17 Years) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
21.3.1.10Pediatric (0 to 17 Years) Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
21.3.2Adult (18 to 64 Years)
21.3.3Geriatric (65 Years and Above)
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 21.3.1 (Pediatric (0 to 17 Years)).
Chapter 22.Global Continuous Glucose Monitoring Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
22.1Introduction
22.2Global Continuous Glucose Monitoring Market Size, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
22.3Global Continuous Glucose Monitoring Market Share, By Connectivity and Integration (%)
22.3.1Standalone CGM
22.3.1.1Market Size, By Standalone CGM, 2020–2034, Revenue (USD Billion)
22.3.1.2Standalone CGM Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
22.3.1.3Standalone CGM Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
22.3.1.4Standalone CGM Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
22.3.1.5Standalone CGM Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
22.3.1.6Standalone CGM Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
22.3.1.7Standalone CGM Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
22.3.1.8Standalone CGM Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
22.3.1.9Standalone CGM Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
22.3.1.10Standalone CGM Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
22.3.2Integrated with Insulin Pumps
22.3.3Integrated with Smart Pens
22.3.4Open-Source and Third-Party Integrated
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 22.3.1 (Standalone CGM).
Chapter 23.Global Continuous Glucose Monitoring Market Overview, By End User, 2020–2034, Revenue (USD Billion)
23.1Introduction
23.2Global Continuous Glucose Monitoring Market Size, By End User, 2020–2034, Revenue (USD Billion)
23.3Global Continuous Glucose Monitoring Market Share, By End User (%)
23.3.1Home Care Settings
23.3.1.1Market Size, By Home Care Settings, 2020–2034, Revenue (USD Billion)
23.3.1.2Home Care Settings Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
23.3.1.3Home Care Settings Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
23.3.1.4Home Care Settings Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
23.3.1.5Home Care Settings Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
23.3.1.6Home Care Settings Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
23.3.1.7Home Care Settings Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
23.3.1.8Home Care Settings Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
23.3.1.9Home Care Settings Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
23.3.1.10Home Care Settings Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
23.3.2Hospitals
23.3.3Clinics and Endocrinology Centers
23.3.4Ambulatory Surgical and Long-Term Care Facilities
23.3.5Research and Clinical Trial Organizations
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 23.3.1 (Home Care Settings).
Chapter 24.Global Continuous Glucose Monitoring Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
24.1Introduction
24.2Global Continuous Glucose Monitoring Market Size, By Distribution Channel, 2020–2034, Revenue (USD Billion)
24.3Global Continuous Glucose Monitoring Market Share, By Distribution Channel (%)
24.3.1Retail Pharmacies
24.3.1.1Market Size, By Retail Pharmacies, 2020–2034, Revenue (USD Billion)
24.3.1.2Retail Pharmacies Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
24.3.1.3Retail Pharmacies Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
24.3.1.4Retail Pharmacies Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
24.3.1.5Retail Pharmacies Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
24.3.1.6Retail Pharmacies Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
24.3.1.7Retail Pharmacies Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
24.3.1.8Retail Pharmacies Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
24.3.1.9Retail Pharmacies Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
24.3.1.10Retail Pharmacies Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
24.3.2Online Pharmacies and E-Commerce
24.3.3Direct-to-Consumer / Manufacturer Direct
24.3.4Durable Medical Equipment Suppliers
24.3.5Hospital Pharmacies
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 24.3.1 (Retail Pharmacies).
Chapter 25.Global Continuous Glucose Monitoring Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
25.1Introduction
25.2Global Continuous Glucose Monitoring Market Size, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
25.3Global Continuous Glucose Monitoring Market Share, By Reimbursement Status (%)
25.3.1Public Insurance Reimbursed
25.3.1.1Market Size, By Public Insurance Reimbursed, 2020–2034, Revenue (USD Billion)
25.3.1.2Public Insurance Reimbursed Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
25.3.1.3Public Insurance Reimbursed Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
25.3.1.4Public Insurance Reimbursed Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
25.3.1.5Public Insurance Reimbursed Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
25.3.1.6Public Insurance Reimbursed Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
25.3.1.7Public Insurance Reimbursed Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
25.3.1.8Public Insurance Reimbursed Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
25.3.1.9Public Insurance Reimbursed Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
25.3.1.10Public Insurance Reimbursed Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
25.3.2Private Insurance Reimbursed
25.3.3Out-of-Pocket
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 25.3.1 (Public Insurance Reimbursed).
Chapter 26.Global Continuous Glucose Monitoring Market Size — Segment Comparison
Chapter 27.Global Continuous Glucose Monitoring Geography Overview, 2020–2034, Revenue (USD Billion)
27.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
27.2Share, By Geography, 2020–2034 (%)
27.3Share, By Geography Analysis, 2025, Market Share and CAGR
27.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Chapter 28.North America Continuous Glucose Monitoring Market Deep-Dive, 2020–2034, Revenue (USD Billion)
28.1Overview, 2020–2034
28.2Size and Projections, 2020–2034, Revenue (USD Billion)
28.2.1By Component, 2020–2034
28.2.2By Product Type, 2020–2034
28.2.3By Sensor Wear Duration, 2020–2034
28.2.4By Sensing Technology, 2020–2034
28.2.5By Application, 2020–2034
28.2.6By Age Group, 2020–2034
28.2.7By Connectivity and Integration, 2020–2034
28.2.8By End User, 2020–2034
28.2.9By Distribution Channel, 2020–2034
28.2.10By Reimbursement Status, 2020–2034
28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
28.3.1US
28.3.1.1US — Key Country Dynamics
28.3.1.2US — Regulatory Framework
28.3.1.3US — Competitive Scenario
28.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
28.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
28.3.1.6US Market Overview, By Component, 2020–2034, Revenue (USD Billion)
28.3.1.7US Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
28.3.1.8US Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
28.3.1.9US Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
28.3.1.10US Market Overview, By Application, 2020–2034, Revenue (USD Billion)
28.3.1.11US Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
28.3.1.12US Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
28.3.1.13US Market Overview, By End User, 2020–2034, Revenue (USD Billion)
28.3.1.14US Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
28.3.1.15US Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
28.3.2Canada
28.3.3Mexico
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 28.3.1 (US).
Chapter 29.Europe Continuous Glucose Monitoring Market Deep-Dive, 2020–2034, Revenue (USD Billion)
29.1Overview, 2020–2034
29.2Size and Projections, 2020–2034, Revenue (USD Billion)
29.2.1By Component, 2020–2034
29.2.2By Product Type, 2020–2034
29.2.3By Sensor Wear Duration, 2020–2034
29.2.4By Sensing Technology, 2020–2034
29.2.5By Application, 2020–2034
29.2.6By Age Group, 2020–2034
29.2.7By Connectivity and Integration, 2020–2034
29.2.8By End User, 2020–2034
29.2.9By Distribution Channel, 2020–2034
29.2.10By Reimbursement Status, 2020–2034
29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
29.3.1Germany
29.3.1.1Germany — Key Country Dynamics
29.3.1.2Germany — Regulatory Framework
29.3.1.3Germany — Competitive Scenario
29.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
29.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
29.3.1.6Germany Market Overview, By Component, 2020–2034, Revenue (USD Billion)
29.3.1.7Germany Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
29.3.1.8Germany Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
29.3.1.9Germany Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
29.3.1.10Germany Market Overview, By Application, 2020–2034, Revenue (USD Billion)
29.3.1.11Germany Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
29.3.1.12Germany Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
29.3.1.13Germany Market Overview, By End User, 2020–2034, Revenue (USD Billion)
29.3.1.14Germany Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
29.3.1.15Germany Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
29.3.2France
29.3.3Italy
29.3.4Spain
29.3.5UK
29.3.6Nordic Countries
29.3.7Benelux Union
29.3.8Rest of Europe
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 29.3.1 (Germany).
Chapter 30.Asia Pacific Continuous Glucose Monitoring Market Deep-Dive, 2020–2034, Revenue (USD Billion)
30.1Overview, 2020–2034
30.2Size and Projections, 2020–2034, Revenue (USD Billion)
30.2.1By Component, 2020–2034
30.2.2By Product Type, 2020–2034
30.2.3By Sensor Wear Duration, 2020–2034
30.2.4By Sensing Technology, 2020–2034
30.2.5By Application, 2020–2034
30.2.6By Age Group, 2020–2034
30.2.7By Connectivity and Integration, 2020–2034
30.2.8By End User, 2020–2034
30.2.9By Distribution Channel, 2020–2034
30.2.10By Reimbursement Status, 2020–2034
30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
30.3.1India
30.3.1.1India — Key Country Dynamics
30.3.1.2India — Regulatory Framework
30.3.1.3India — Competitive Scenario
30.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
30.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
30.3.1.6India Market Overview, By Component, 2020–2034, Revenue (USD Billion)
30.3.1.7India Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
30.3.1.8India Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
30.3.1.9India Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
30.3.1.10India Market Overview, By Application, 2020–2034, Revenue (USD Billion)
30.3.1.11India Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
30.3.1.12India Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
30.3.1.13India Market Overview, By End User, 2020–2034, Revenue (USD Billion)
30.3.1.14India Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
30.3.1.15India Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
30.3.2Australia
30.3.3China
30.3.4China (Taiwan)
30.3.5Japan
30.3.6South Korea
30.3.7Southeast Asia
30.3.8Indonesia
30.3.9Thailand
30.3.10Malaysia
30.3.11Singapore
30.3.12Rest of Asia Pacific
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 30.3.1 (India).
Chapter 31.Latin America Continuous Glucose Monitoring Market Deep-Dive, 2020–2034, Revenue (USD Billion)
31.1Overview, 2020–2034
31.2Size and Projections, 2020–2034, Revenue (USD Billion)
31.2.1By Component, 2020–2034
31.2.2By Product Type, 2020–2034
31.2.3By Sensor Wear Duration, 2020–2034
31.2.4By Sensing Technology, 2020–2034
31.2.5By Application, 2020–2034
31.2.6By Age Group, 2020–2034
31.2.7By Connectivity and Integration, 2020–2034
31.2.8By End User, 2020–2034
31.2.9By Distribution Channel, 2020–2034
31.2.10By Reimbursement Status, 2020–2034
31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
31.3.1Brazil
31.3.1.1Brazil — Key Country Dynamics
31.3.1.2Brazil — Regulatory Framework
31.3.1.3Brazil — Competitive Scenario
31.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
31.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
31.3.1.6Brazil Market Overview, By Component, 2020–2034, Revenue (USD Billion)
31.3.1.7Brazil Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
31.3.1.8Brazil Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
31.3.1.9Brazil Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
31.3.1.10Brazil Market Overview, By Application, 2020–2034, Revenue (USD Billion)
31.3.1.11Brazil Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
31.3.1.12Brazil Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
31.3.1.13Brazil Market Overview, By End User, 2020–2034, Revenue (USD Billion)
31.3.1.14Brazil Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
31.3.1.15Brazil Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
31.3.2Argentina
31.3.3Rest of Latin America
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 31.3.1 (Brazil).
Chapter 32.Middle East and Africa Continuous Glucose Monitoring Market Deep-Dive, 2020–2034, Revenue (USD Billion)
32.1Overview, 2020–2034
32.2Size and Projections, 2020–2034, Revenue (USD Billion)
32.2.1By Component, 2020–2034
32.2.2By Product Type, 2020–2034
32.2.3By Sensor Wear Duration, 2020–2034
32.2.4By Sensing Technology, 2020–2034
32.2.5By Application, 2020–2034
32.2.6By Age Group, 2020–2034
32.2.7By Connectivity and Integration, 2020–2034
32.2.8By End User, 2020–2034
32.2.9By Distribution Channel, 2020–2034
32.2.10By Reimbursement Status, 2020–2034
32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
32.3.1GCC
32.3.1.1GCC — Key Country Dynamics
32.3.1.2GCC — Regulatory Framework
32.3.1.3GCC — Competitive Scenario
32.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
32.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
32.3.1.6GCC Market Overview, By Component, 2020–2034, Revenue (USD Billion)
32.3.1.7GCC Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
32.3.1.8GCC Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
32.3.1.9GCC Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
32.3.1.10GCC Market Overview, By Application, 2020–2034, Revenue (USD Billion)
32.3.1.11GCC Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
32.3.1.12GCC Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
32.3.1.13GCC Market Overview, By End User, 2020–2034, Revenue (USD Billion)
32.3.1.14GCC Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
32.3.1.15GCC Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
32.3.2Egypt
32.3.3South Africa
32.3.4Rest of the Middle East & Africa
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 32.3.1 (GCC).
Chapter 33.Application / Use-Case Analysis
Chapter 34.Vendor Capability Scorecard
Chapter 35.Scenario Forecasts
35.1Bull-case Trajectory
35.2Base-case Trajectory
35.3Bear-case Trajectory
Chapter 36.Top 10 Key Clients of Top 10 Players
Chapter 37.Top 10 Suppliers
Chapter 38.Competitive Landscape
38.1Dexcom, Inc.
38.2Abbott Laboratories
38.3Medtronic plc
38.4F. Hoffmann-La Roche Ltd
38.5Senseonics Holdings, Inc.
38.6Insulet Corporation
38.7Tandem Diabetes Care, Inc.
38.8Ascensia Diabetes Care Holdings AG
38.9LifeScan, Inc.
38.10Sinocare Inc.
38.11Medtrum Technologies Inc.
38.12Roche Diabetes Care GmbH
38.13i-SENS, Inc.
38.14Glucotrack, Inc.
38.15Biolinq, Inc.
38.16Embecta Corp.
38.17Terumo Corporation
38.18Yuwell Medical (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)
38.19Microtech Medical (Hangzhou) Co., Ltd.
38.20Ypsomed Holding AG
38.21Diabeloop SA
38.22Trividia Health, Inc.
38.23Nemaura Medical Inc.
38.24Dexcom Europe / Eversense partner Ascensia
38.25Meiqi / Shenzhen Silicon Biotech Co., Ltd.
38.26Glucomen / A. Menarini Diagnostics S.r.l.
38.27Sibionics (Shenzhen Sibionics Technology Co., Ltd.)
Chapter 39.Partnerships & M&A
Chapter 40.Key Vendor Analysis
40.1Dexcom, Inc.
40.2Abbott Laboratories
40.3Medtronic plc
40.4F. Hoffmann-La Roche Ltd
40.5Senseonics Holdings, Inc.
40.6Insulet Corporation
40.7Tandem Diabetes Care, Inc.
40.8Ascensia Diabetes Care Holdings AG
40.9LifeScan, Inc.
40.10Sinocare Inc.
40.11Medtrum Technologies Inc.
40.12Roche Diabetes Care GmbH
40.13i-SENS, Inc.
40.14Glucotrack, Inc.
40.15Biolinq, Inc.
40.16Embecta Corp.
40.17Terumo Corporation
40.18Yuwell Medical (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)
40.19Microtech Medical (Hangzhou) Co., Ltd.
40.20Ypsomed Holding AG
40.21Diabeloop SA
40.22Trividia Health, Inc.
40.23Nemaura Medical Inc.
40.24Dexcom Europe / Eversense partner Ascensia
40.25Meiqi / Shenzhen Silicon Biotech Co., Ltd.
40.26Glucomen / A. Menarini Diagnostics S.r.l.
40.27Sibionics (Shenzhen Sibionics Technology Co., Ltd.)
Chapter 41.Marketing Strategy Analysis, Distributors & Traders
Chapter 42.Outlook of the Market
Chapter 43.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
Figure 2.1Top 3 Trends to Watch
Figure 2.4Top Investment Pockets
Figure 2.4.1Market Attractiveness Analysis, By Component
Figure 2.4.2Market Attractiveness Analysis, By Product Type
Figure 2.4.3Market Attractiveness Analysis, By Sensor Wear Duration
Figure 2.4.4Market Attractiveness Analysis, By Sensing Technology
Figure 2.4.5Market Attractiveness Analysis, By Application
Figure 2.4.6Market Attractiveness Analysis, By Age Group
Figure 2.4.7Market Attractiveness Analysis, By Connectivity and Integration
Figure 2.4.8Market Attractiveness Analysis, By End User
Figure 2.4.9Market Attractiveness Analysis, By Distribution Channel
Figure 2.4.10Market Attractiveness Analysis, By Reimbursement Status
Figure 2.5Key Market Participants — Intensity Mapping
Figure 4.2.2.2Data Triangulation
Figure 4.3Flow Of Methodology
Figure 4.4Top-Down / Bottom-Up Approach
Figure 6.1.2Product Differentiation and Positioning Logic
Figure 16.3Global Continuous Glucose Monitoring Market Share, By Component (%)
Figure 17.3Global Continuous Glucose Monitoring Market Share, By Product Type (%)
Figure 18.3Global Continuous Glucose Monitoring Market Share, By Sensor Wear Duration (%)
Figure 19.3Global Continuous Glucose Monitoring Market Share, By Sensing Technology (%)
Figure 20.3Global Continuous Glucose Monitoring Market Share, By Application (%)
Figure 21.3Global Continuous Glucose Monitoring Market Share, By Age Group (%)
Figure 22.3Global Continuous Glucose Monitoring Market Share, By Connectivity and Integration (%)
Figure 23.3Global Continuous Glucose Monitoring Market Share, By End User (%)
Figure 24.3Global Continuous Glucose Monitoring Market Share, By Distribution Channel (%)
Figure 25.3Global Continuous Glucose Monitoring Market Share, By Reimbursement Status (%)
Figure 27.2Share, By Geography, 2020–2034 (%)
Figure 27.3Share, By Geography Analysis, 2025, Market Share and CAGR
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Table 1.3Continuous Glucose Monitoring Comparison By Segments
Table 4.1.2Market Size Estimation
Table 15.1Global Continuous Glucose Monitoring Market Size — Total
Table 15.2Market Size, by Segment (By Component, By Product Type, By Sensor Wear Duration, By Sensing Technology, By Application, By Age Group, By Connectivity and Integration, By End User, By Distribution Channel, By Reimbursement Status)
Table 16.2Global Continuous Glucose Monitoring Market Size, By Component, 2020–2034, Revenue (USD Billion)
Table 16.3.1.1Market Size, By Sensors, 2020–2034, Revenue (USD Billion)
Table 16.3.1.2Sensors Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.3Sensors Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 16.3.1.4Sensors Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 16.3.1.5Sensors Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 16.3.1.6Sensors Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 16.3.1.7Sensors Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 16.3.1.8Sensors Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 16.3.1.9Sensors Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 16.3.1.10Sensors Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 17.2Global Continuous Glucose Monitoring Market Size, By Product Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.1Market Size, By Real-Time CGM (rtCGM), 2020–2034, Revenue (USD Billion)
Table 17.3.1.2Real-Time CGM (rtCGM) Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 17.3.1.3Real-Time CGM (rtCGM) Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 17.3.1.4Real-Time CGM (rtCGM) Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 17.3.1.5Real-Time CGM (rtCGM) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 17.3.1.6Real-Time CGM (rtCGM) Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 17.3.1.7Real-Time CGM (rtCGM) Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 17.3.1.8Real-Time CGM (rtCGM) Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 17.3.1.9Real-Time CGM (rtCGM) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 17.3.1.10Real-Time CGM (rtCGM) Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 18.2Global Continuous Glucose Monitoring Market Size, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 18.3.1.1Market Size, By Up to 7 Days, 2020–2034, Revenue (USD Billion)
Table 18.3.1.2Up to 7 Days Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 18.3.1.3Up to 7 Days Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.4Up to 7 Days Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 18.3.1.5Up to 7 Days Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 18.3.1.6Up to 7 Days Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 18.3.1.7Up to 7 Days Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 18.3.1.8Up to 7 Days Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 18.3.1.9Up to 7 Days Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 18.3.1.10Up to 7 Days Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 19.2Global Continuous Glucose Monitoring Market Size, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 19.3.1.1Market Size, By Minimally Invasive Enzymatic Electrochemical, 2020–2034, Revenue (USD Billion)
Table 19.3.1.2Minimally Invasive Enzymatic Electrochemical Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 19.3.1.3Minimally Invasive Enzymatic Electrochemical Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.4Minimally Invasive Enzymatic Electrochemical Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 19.3.1.5Minimally Invasive Enzymatic Electrochemical Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 19.3.1.6Minimally Invasive Enzymatic Electrochemical Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 19.3.1.7Minimally Invasive Enzymatic Electrochemical Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 19.3.1.8Minimally Invasive Enzymatic Electrochemical Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 19.3.1.9Minimally Invasive Enzymatic Electrochemical Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 19.3.1.10Minimally Invasive Enzymatic Electrochemical Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 20.2Global Continuous Glucose Monitoring Market Size, By Application, 2020–2034, Revenue (USD Billion)
Table 20.3.1.1Market Size, By Type 1 Diabetes, 2020–2034, Revenue (USD Billion)
Table 20.3.1.2Type 1 Diabetes Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 20.3.1.3Type 1 Diabetes Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.4Type 1 Diabetes Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 20.3.1.5Type 1 Diabetes Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 20.3.1.6Type 1 Diabetes Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 20.3.1.7Type 1 Diabetes Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 20.3.1.8Type 1 Diabetes Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 20.3.1.9Type 1 Diabetes Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 20.3.1.10Type 1 Diabetes Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 21.2Global Continuous Glucose Monitoring Market Size, By Age Group, 2020–2034, Revenue (USD Billion)
Table 21.3.1.1Market Size, By Pediatric (0 to 17 Years), 2020–2034, Revenue (USD Billion)
Table 21.3.1.2Pediatric (0 to 17 Years) Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 21.3.1.3Pediatric (0 to 17 Years) Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.4Pediatric (0 to 17 Years) Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 21.3.1.5Pediatric (0 to 17 Years) Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 21.3.1.6Pediatric (0 to 17 Years) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 21.3.1.7Pediatric (0 to 17 Years) Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 21.3.1.8Pediatric (0 to 17 Years) Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 21.3.1.9Pediatric (0 to 17 Years) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 21.3.1.10Pediatric (0 to 17 Years) Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 22.2Global Continuous Glucose Monitoring Market Size, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 22.3.1.1Market Size, By Standalone CGM, 2020–2034, Revenue (USD Billion)
Table 22.3.1.2Standalone CGM Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 22.3.1.3Standalone CGM Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.4Standalone CGM Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 22.3.1.5Standalone CGM Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 22.3.1.6Standalone CGM Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 22.3.1.7Standalone CGM Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 22.3.1.8Standalone CGM Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 22.3.1.9Standalone CGM Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 22.3.1.10Standalone CGM Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 23.2Global Continuous Glucose Monitoring Market Size, By End User, 2020–2034, Revenue (USD Billion)
Table 23.3.1.1Market Size, By Home Care Settings, 2020–2034, Revenue (USD Billion)
Table 23.3.1.2Home Care Settings Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 23.3.1.3Home Care Settings Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.4Home Care Settings Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 23.3.1.5Home Care Settings Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 23.3.1.6Home Care Settings Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 23.3.1.7Home Care Settings Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 23.3.1.8Home Care Settings Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 23.3.1.9Home Care Settings Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 23.3.1.10Home Care Settings Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 24.2Global Continuous Glucose Monitoring Market Size, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 24.3.1.1Market Size, By Retail Pharmacies, 2020–2034, Revenue (USD Billion)
Table 24.3.1.2Retail Pharmacies Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 24.3.1.3Retail Pharmacies Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.4Retail Pharmacies Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 24.3.1.5Retail Pharmacies Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 24.3.1.6Retail Pharmacies Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 24.3.1.7Retail Pharmacies Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 24.3.1.8Retail Pharmacies Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 24.3.1.9Retail Pharmacies Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 24.3.1.10Retail Pharmacies Size and Projections, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 25.2Global Continuous Glucose Monitoring Market Size, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 25.3.1.1Market Size, By Public Insurance Reimbursed, 2020–2034, Revenue (USD Billion)
Table 25.3.1.2Public Insurance Reimbursed Size and Projections, By Component, 2020–2034, Revenue (USD Billion)
Table 25.3.1.3Public Insurance Reimbursed Size and Projections, By Product Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.4Public Insurance Reimbursed Size and Projections, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 25.3.1.5Public Insurance Reimbursed Size and Projections, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 25.3.1.6Public Insurance Reimbursed Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 25.3.1.7Public Insurance Reimbursed Size and Projections, By Age Group, 2020–2034, Revenue (USD Billion)
Table 25.3.1.8Public Insurance Reimbursed Size and Projections, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 25.3.1.9Public Insurance Reimbursed Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 25.3.1.10Public Insurance Reimbursed Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 27.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
Table 27.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.1Overview, 2020–2034
Table 28.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.2.1By Component, 2020–2034
Table 28.2.2By Product Type, 2020–2034
Table 28.2.3By Sensor Wear Duration, 2020–2034
Table 28.2.4By Sensing Technology, 2020–2034
Table 28.2.5By Application, 2020–2034
Table 28.2.6By Age Group, 2020–2034
Table 28.2.7By Connectivity and Integration, 2020–2034
Table 28.2.8By End User, 2020–2034
Table 28.2.9By Distribution Channel, 2020–2034
Table 28.2.10By Reimbursement Status, 2020–2034
Table 28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
Table 28.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.3.1.6US Market Overview, By Component, 2020–2034, Revenue (USD Billion)
Table 28.3.1.7US Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.8US Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 28.3.1.9US Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 28.3.1.10US Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 28.3.1.11US Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
Table 28.3.1.12US Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 28.3.1.13US Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 28.3.1.14US Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 28.3.1.15US Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 29.1Overview, 2020–2034
Table 29.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.2.1By Component, 2020–2034
Table 29.2.2By Product Type, 2020–2034
Table 29.2.3By Sensor Wear Duration, 2020–2034
Table 29.2.4By Sensing Technology, 2020–2034
Table 29.2.5By Application, 2020–2034
Table 29.2.6By Age Group, 2020–2034
Table 29.2.7By Connectivity and Integration, 2020–2034
Table 29.2.8By End User, 2020–2034
Table 29.2.9By Distribution Channel, 2020–2034
Table 29.2.10By Reimbursement Status, 2020–2034
Table 29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 29.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
Table 29.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.3.1.6Germany Market Overview, By Component, 2020–2034, Revenue (USD Billion)
Table 29.3.1.7Germany Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.8Germany Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 29.3.1.9Germany Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 29.3.1.10Germany Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 29.3.1.11Germany Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
Table 29.3.1.12Germany Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 29.3.1.13Germany Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 29.3.1.14Germany Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 29.3.1.15Germany Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 30.1Overview, 2020–2034
Table 30.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.2.1By Component, 2020–2034
Table 30.2.2By Product Type, 2020–2034
Table 30.2.3By Sensor Wear Duration, 2020–2034
Table 30.2.4By Sensing Technology, 2020–2034
Table 30.2.5By Application, 2020–2034
Table 30.2.6By Age Group, 2020–2034
Table 30.2.7By Connectivity and Integration, 2020–2034
Table 30.2.8By End User, 2020–2034
Table 30.2.9By Distribution Channel, 2020–2034
Table 30.2.10By Reimbursement Status, 2020–2034
Table 30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 30.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
Table 30.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.3.1.6India Market Overview, By Component, 2020–2034, Revenue (USD Billion)
Table 30.3.1.7India Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.8India Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 30.3.1.9India Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 30.3.1.10India Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 30.3.1.11India Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
Table 30.3.1.12India Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 30.3.1.13India Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 30.3.1.14India Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 30.3.1.15India Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 31.1Overview, 2020–2034
Table 31.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.2.1By Component, 2020–2034
Table 31.2.2By Product Type, 2020–2034
Table 31.2.3By Sensor Wear Duration, 2020–2034
Table 31.2.4By Sensing Technology, 2020–2034
Table 31.2.5By Application, 2020–2034
Table 31.2.6By Age Group, 2020–2034
Table 31.2.7By Connectivity and Integration, 2020–2034
Table 31.2.8By End User, 2020–2034
Table 31.2.9By Distribution Channel, 2020–2034
Table 31.2.10By Reimbursement Status, 2020–2034
Table 31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 31.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
Table 31.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.3.1.6Brazil Market Overview, By Component, 2020–2034, Revenue (USD Billion)
Table 31.3.1.7Brazil Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.8Brazil Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 31.3.1.9Brazil Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 31.3.1.10Brazil Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 31.3.1.11Brazil Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
Table 31.3.1.12Brazil Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 31.3.1.13Brazil Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 31.3.1.14Brazil Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 31.3.1.15Brazil Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Table 32.1Overview, 2020–2034
Table 32.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.2.1By Component, 2020–2034
Table 32.2.2By Product Type, 2020–2034
Table 32.2.3By Sensor Wear Duration, 2020–2034
Table 32.2.4By Sensing Technology, 2020–2034
Table 32.2.5By Application, 2020–2034
Table 32.2.6By Age Group, 2020–2034
Table 32.2.7By Connectivity and Integration, 2020–2034
Table 32.2.8By End User, 2020–2034
Table 32.2.9By Distribution Channel, 2020–2034
Table 32.2.10By Reimbursement Status, 2020–2034
Table 32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 32.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
Table 32.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.3.1.6GCC Market Overview, By Component, 2020–2034, Revenue (USD Billion)
Table 32.3.1.7GCC Market Overview, By Product Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.8GCC Market Overview, By Sensor Wear Duration, 2020–2034, Revenue (USD Billion)
Table 32.3.1.9GCC Market Overview, By Sensing Technology, 2020–2034, Revenue (USD Billion)
Table 32.3.1.10GCC Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 32.3.1.11GCC Market Overview, By Age Group, 2020–2034, Revenue (USD Billion)
Table 32.3.1.12GCC Market Overview, By Connectivity and Integration, 2020–2034, Revenue (USD Billion)
Table 32.3.1.13GCC Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 32.3.1.14GCC Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 32.3.1.15GCC Market Overview, By Reimbursement Status, 2020–2034, Revenue (USD Billion)
Scope
Questions This Report Answers
6 questions01
What is the market size and growth rate, globally and by region?
02
How is the market segmented, and which segments lead?
03
Which regions and countries are covered, and how do they compare?
04
What are the key drivers, restraints, opportunities and challenges?
05
Who are the leading companies operating in this market?
06
What trends are expected to shape the market through the forecast period?
Questions
Frequently Asked Questions
01What is the Continuous Glucose Monitoring Market projected to reach?
USD 36 USD Billion by 2034, CAGR 11.47%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 45% of global revenue through 2034.
05Which segment leads the market?
Sensors is the largest line by Component, at 52% of revenue in 2025.
06Who are the key companies profiled?
Dexcom, Inc., Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd, Senseonics Holdings, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Ascensia Diabetes Care Holdings AG, LifeScan, Inc., Sinocare Inc., Medtrum Technologies Inc., Roche Diabetes Care GmbH, i-SENS, Inc., Glucotrack, Inc., Biolinq, Inc., Embecta Corp., Terumo Corporation, Yuwell Medical (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Microtech Medical (Hangzhou) Co., Ltd., Ypsomed Holding AG, Diabeloop SA, Trividia Health, Inc., Nemaura Medical Inc., Dexcom Europe / Eversense partner Ascensia, Meiqi / Shenzhen Silicon Biotech Co., Ltd., Glucomen / A. Menarini Diagnostics S.r.l., Sibionics (Shenzhen Sibionics Technology Co., Ltd.). Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
425+
Dedicated research analysts
1,200+
Reports published
Why CDI
Why choose CDI
Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.
Explore
Related Reports
Medical Devices
Remote Patient Monitoring Market
USD 70.8 Bn by 2034, CAGR 11.3%
Medical Devices
Smart Inhaler Technology Market
USD 10.3 Bn by 2034, CAGR 14.78%
Medical Devices
Parenteral Packaging Market
USD 47.71 Bn by 2034, CAGR 6.31%
Medical Devices
Pen Needles Market
USD 10.02 Bn by 2034, CAGR 9.41%
Electronics & Semiconductors
Brain Monitoring Market
USD 11.54 Bn by 2034, CAGR 8.75%
Medical Devices
Ivf Syringes Market
USD 3.2 Bn by 2034, CAGR 9.75%